Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Quality of life
[71] RCT	544 people Further report of reference [51]	Proportion of people with no/minimal social impairment following treatment 6 months 78/125 (62%) with venlafaxine (37.5 mg/day) 83/115 (72%) with venlafaxine (75 mg/day) 94/118 (80%) with venlafaxine (150 mg/day) 63/111 (56%) with placebo	Significance not assessed